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BENZODIAZEPINES FOR PROMINENT AUDITORY 
HALLUCINATIONS: A REPORT AND HYPOTHESIS. 
CHITTARANJAN ANDRADE 
A case is reported of diazepam - induced amelioration of prominent auditory hallucinations experienced 
by a female paranoid schizophrenic. With the assumption that subvocal speech may be primary to such 
hallucinations, it is proposed that diazepam may have acted by exerting a relaxant effect on speech 
musculature. This is a hypothesis testable in future research. 
Key words: benzodiazepines, schizophrenia, hallucination. 
In recent years, benzodiazepines have been found 
to be useful, either alone or as adjuncts to neurolep-
tics in the management of psychosis. The consensus 
of opinion seems to be that benzodiazepines hasten 
amelioration of agitated states and lower the 
neuroleptic requirement. The response is highly 
variable and about 30-50% of patients improve. 
Actual antipsychotic effects may be observed in 
some* patients and higher doses (but not necessarily 
megadoses) are probably more effective (Bodkin, 
1990; Wolkowitz & Pickar, 1991; Ananth & Solano, 
1993). A case with prominent auditory hallucina-
tions responding to diazepam is herein reported. 
Possible explanations for the response are discussed 
and a testable hypothesis is suggested. 
CASE REPORT 
From 1986, a male paranoid schizophrenic has 
been followed up regularly in the company of his 40 
year old wife, Mrs. V. At one follow up in 1992, Mrs. 
V. reported that since a fortnight she had begun to 
hear voices at both office and home. The content of 
these hallucinations was in general derogatory and 
abusive - for example suggesting that she was an 
immoral woman. 
The voices appeared for an hour or longer per 
occasion for several occasions a day. The voices 
were heard in clear consciousness and were located 
in objective space. Mrs. V. readily agreed that hear-
ing such voices was abnormal and indicative of a 
psychiatric disorder, such as that from which her 
husband was suffering. There was no disturbance of 
thought, behavior or function outside her hallucina-
tions; in fact, other than anxiety due to her symptom, 
Mrs. V. did not appear m uch different from what she 
had been over the past years. 
There was no history to suggest an organic origin 
for the hallucinations. There was, however, a history 
of recent nonspecific stress both at work and at 
home, in addition to the existent stress of looking 
after a schizophrenic husband. Physical examination 
was unremarkable. There were no visible move-
ments of orofacial or superficial laryngeal muscula-
ture (the patient was actively hallucinating during 
this presentation), nor did the patient complain of 
orofacial or throat movements or sensations during 
the hallucinatory episodes (such movements or sen-
sations may be observed or reported by patients who 
experience continuous auditory hallucinations). 
Reports from the Indian subcontinent have sug-
gested that true hallucinations may present as a 
culturally sanctioned conversion symptom in non-
psychotic states (Andrade & Srinath, 1986; Andrade 
et al, 1988 & 1989). In view of the stress, Mrs. V.'s 
excellent insight, the preservation of occupational 
functioning, the absence of other symptoms charac-
teristic of psychosis, and the opportunity to 'leam' a 
symptom from her husband, a tentative diagnosis of 
Adjustment Disorder (with predominant distur-
bance of other emotions), ICD-9 309.2 was made. It 
was decided to maintain close contact with Mrs. V. 
so that immediate neuroleptic treatment could be 
instituted should it become necessary to revise the 
diagnosis to one of psychosis. 
She was prescribed diazepam in the dose of 2.5 
mg in the morning and 5 mg at night to relieve the 
manifest anxiety associated with her s%mpu>m. No 
more than reassurance was offered, with the com-
mitment that a psychoeducational program for the 
disorder would be undertaken at a follow up appoint-
ment given for the next week. At the scheduled 
follow up, Mrs. V. reported a substantial decrease in 
the occurrence of hallucinations - the symptoms 
occurred on no more than two or three occasions a 
day for a few minutes each time. Diazepam was 
therefore continued for a further two weeks, over 
which period weekly contact was maintained. There 
was no further clinical improvement; however, 
towards the end of the third week of therapy, Mrs. 
V. began to exhibit new symptoms - the convictions 
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(of delusional proportions) that she could read 
minds, that she could project thoughts, and that her 
colleagues and neighbors were persecuting her. In 
addition, her sleep and appetite became disturbed 
and she was socially withdrawn. Her work perfor-
mance began to suffer. A diagnosis of paranoid 
schizophrenia became inevitable. 
Diazepam was withdrawn and neuroleptic 
therapy was immediately commenced. Mrs.V. 
showed a good response and today, two years later, 
she remains in reasonably good remission on 
neuroleptic maintenance medication. 
DISCUSSION 
Many mechanisms have been proposed for the 
response of psychosis to benzodiazepines. One is 
that benzodiazepines nonspecifically reduce 
arousal, therapy decreasing anxiety, agitation, ex-
citement and related symptoms associated with 
psychosis (Ananth & Solano, 1993). Although Mrs. 
V. was anxious at initial presentation, the degree of 
anxiety was not marked. Furthermore, there was no 
his'ory of precipitation of anxiety symptoms or 
heightening of existent anxiety immediately preced-
ing each hallucinatory episode. It seems unlikely 
that merely reduction in her anxiety could have 
induced such a striking lessening of the hal-
lucinatory experiences. 
Another mechanism proposed is that ben-
zodiazepines inhibit dopaminergic neurotransmis-
sion either directly or through activation of the 
benzodiazepine / GAI3A receptor complex. This 
may explain the response of core psychotic 
symptoms (such as Mrs. V.'s hallucinations) to 
diazepam. The mechanisms of action of ben-
zodiazepines in psychosis have been well reviewed 
by Wolkowitz and Pickar (1991). 
A third explanation is also possible. It has been 
hypothesized that auditory hallucinations result 
from subvocal speech (detectable in 
electromyographic records from orofacial and laryn-
geal musculature). Interventions that interfere with 
subvocalizations reduce auditory hallucinations 
(Bick & KJnsboume, 1987; Green & Kinsbourne, 
1990). Diazepam is a potent muscle relaxant and by 
virtue of this property, may reduce subvocal activity. 
This effect could explain the dramatic reduction of 
hallucinations experienced by Mrs. V. following the 
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onset of diazepam therapy. Another recent report 
(Banes et al, 1993) has also documented a dramatic 
response ofschizophrenic auditory hallucinations to 
a benzodiazepine (etizolam). 
The proposal that benzodiazepines induce reduc-
tion of electromyographic activity in orofacial and 
laryngeal musculature, which in turn leads to a 
reduction in the frequency of auditory hallucina-
tions, is an eminently testable hypothesis. Should 
this hypothesis be borne out, benzodiazepines for 
prominent auditory hallucinations may prove viable 
- possibly more so than behavior therapy techniques 
that seek to interrupt subvocal speech. 
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